Posts Tagged:ALS

Hadassah and Neurogenesis announce results from Phase 2 MS Study

by

A Phase 2 study at Hadassah Hospital Ein Kerem has revealed significant clinical improvements in patients with progressive multiple sclerosis (MS) after being treated with NG-01 stem cells developed by NeuroGenesis, a clinical-stage biopharmaceutical company advancing innovative cell therapies to combat neurodegenerative diseases. The 14-month randomized, double blind, placebo-controlled study, comprised of 48 patients, was led by Prof.…



“Hadassah in the News” with new Motor Neurone Disease research trial

by

“Hadassah in the News” New Agreements for Human Embryonic Stem Cells Developed at Hadassah The Israeli Ministry of Health’s Supreme Committee granted approval yesterday to conduct the first two phases (I/Iia) clinical trial with Amyotrophic lateral sclerosis (ALS) patients also known as Motor Neurone Disease (MND), and Lou Gehrig’s disease, using a unique cell therapy.…



A Culture of Research.

by

From developing a melanoma vaccine to working on controlling diabetes, Hadassah’s multidisciplinary, collaborative approach is resulting in medical breakthroughs and innovations. Tens of thousands bless Travelan, the over-the-counter natural health product that helps prevent traveler’s diarrhea. The ultrasound device PainShield has wrought a revolution in healing chronic wounds. And PerioChip, inserted between tooth and gum,…



DONATE NOW

Donate

£

Please enter above the amount you would like to donate

Personal Info

25% more with Gift Aid
Billing Details

Donation Total: £25.00

Contact Us

Hadassah UK
25 The Burroughs
Hendon, London
NW4 4AR
Tel: 0208 202 2860
Email: uk.office(at)hadassah.org.uk
Registered Charity No. 1040848
Terms, Conditions and Policies

Check us out on Facebook